Upgrade to SI Premium - Free Trial

Form 3 COLGATE PALMOLIVE CO For: Jun 01 Filed by: Fishbone Betsy

June 5, 2026 4:13 PM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Fishbone Betsy
(Last) (First) (Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
(Street)
NEW YORK NY 10022
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2026 		3. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CLO and Secretary
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 15,021
D
Common Stock 50
I
By Family Member
Common Stock 8,336
I
By Issuer's 401(k) Plan Trustee
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 09/13/2031 Common Stock 9,944 72.83 D
Stock Option (Right to Buy) (2) 09/10/2029 Common Stock 19,012 77.04 D
Stock Option (Right to Buy) (3) 09/09/2030 Common Stock 16,612 78.03 D
Stock Option (Right to Buy) (4) 09/11/2033 Common Stock 9,392 84.06 D
Stock Option (Right to Buy) (5) 09/12/2032 Common Stock 6,848 106.34 D
Explanation of Responses:
1. Option became exercisable in one-third increments beginning on the first anniversary of the September 13, 2023 grant date.
2. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2021 grant date.
3. Option became exercisable in one-third increments beginning on the first anniversary of the September 9, 2022 grant date.
4. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 11, 2025 grant date.
5. Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2024 grant date.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Kristine Hutchinson, Attorney-in-Fact 06/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

ATTACHMENTS / EXHIBITS

fishbonepoa.txt

Categories

SEC Filings